Age-dependent changes in susceptibility to ototoxic hearing loss

Area of Science:

• Ototoxicology
• Neuroscience
• Pharmacology

Background:

• Age-dependent changes in susceptibility to noise- and drug-induced hearing loss are observed in various species.
• Aminoglycosides like kanamycin are known ototoxic agents, but their interaction with other drugs and age is not fully understood.

Purpose of the Study:

• To investigate the age-dependent susceptibility of mice to ototoxic hearing loss induced by kanamycin and bumetanide.
• To evaluate the potential of a combined drug treatment for defining critical periods of auditory system vulnerability.

Main Methods:

• 18-day-old mice received kanamycin (200 mg/kg) with varying doses of bumetanide (20, 30, or 40 mg/kg).
• Auditory nerve function was assessed using scalp-recorded compound action potential thresholds.
• 38-day-old mice were treated with kanamycin (200 mg/kg) and bumetanide (40 mg/kg) for comparison.

Main Results:

• Diuretic doses of bumetanide (30 and 40 mg/kg) significantly reduced hearing sensitivity in 18-day-old mice when co-administered with kanamycin.
• 38-day-old mice treated with the same kanamycin and bumetanide combination showed no significant hearing loss.
• These findings demonstrate a clear age-dependent difference in susceptibility to ototoxic hearing loss.

Conclusions:

• The study confirms that the susceptibility to ototoxic hearing loss in mice is age-dependent.
• The combined kanamycin and bumetanide treatment protocol can be a valuable tool for more precisely defining the critical period of auditory vulnerability.
• This approach offers a refined method for studying age-related hearing loss mechanisms.